Results 181 to 190 of about 167,277 (295)

Development of NP-Based Universal Vaccine for Influenza A Viruses. [PDF]

Vaccines (Basel)
Sayedahmed EE, Elshafie NO, Dos Santos AP, Jagannath C, Sambhara S, Mittal SK.   +5 more
europepmc   +1 more source

Genomic Diversity and Hotspot Mutations in 30,983 SARS-CoV-2 Genomes: Moving Toward a Universal Vaccine for the "Confined Virus"? [PDF]

Pathogens, 2020
Alouane T, Laamarti M, Essabbar A, Hakmi M, Bouricha EM, Chemao-Elfihri MW, Kartti S, Boumajdi N, Bendani H, Laamarti R, Ghrifi F, Allam L, Aanniz T, Ouadghiri M, El Hafidi N, El Jaoudi R, Benrahma H, Attar JE, Mentag R, Sbabou L, Nejjari C, Amzazi S, Belyamani L, Ibrahimi A.   +23 more
europepmc   +1 more source

The surge of universal influenza vaccines [PDF]

Pathogens and Global Health, 2017
openaire   +2 more sources

Physicians' hybridisation with accounting in public hospitals

Accounting &Finance, EarlyView.
Abstract Accounting information has become an integral part of management tools in public hospitals. Following COVID‐19, the crisis in the supply chain and the war in Ukraine severely impacted the financing of public hospitals. In response to this multi‐crisis environment, physicians have increased their awareness on an efficient use of scarce ...
Susana Gago‐Rodríguez, Amélia Ferreira‐da‐Silva, Belen Fernandez‐Feijoo   +2 more
wiley   +1 more source

Influenza Anti-Stalk Antibodies: Development of a New Method for the Evaluation of the Immune Responses to Universal Vaccine. [PDF]

Vaccines (Basel), 2020
Manenti A, Maciola AK, Trombetta CM, Kistner O, Casa E, Hyseni I, Razzano I, Torelli A, Montomoli E.   +8 more
europepmc   +1 more source

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved.
Lene H. Garvey, Knut Brockow, Annick Barbaud, Charlotte G. Mortz, Gianfranco Calogiuri, Asli Gelincik, Osman O. Yeğit, Alla Nakonechna, Annette Wagner, Rik Schrijvers, Toon Ieven   +10 more
wiley   +1 more source

Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond. [PDF]

Infect Dis Poverty
Chen S, Rodewald LE, Du AH, Tang S.
europepmc   +1 more source

The Functional Role and Molecular Characterization of the Therapeutic Target CLDN6 in Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Background The tight junction protein CLDN6 has been identified as a cancer‐associated cell surface marker that is rarely expressed in healthy tissues. In testicular germ cell tumors (GCT), CLDN6 is particularly detectable in seminomas, embryonal carcinomas, and choriocarcinomas.
Jule Zwick, Margaretha A. Skowron, Gereon Poschmann, Patrick Petzsch, Ann Kathrin Bergmann, Kai Stühler, Jochen Hecht, Daniel Nettersheim   +7 more
wiley   +1 more source

Potential of histamine release factor for the utilization as a universal vaccine antigen against poultry red mites, tropical fowl mites, and northern fowl mites. [PDF]

J Vet Med Sci
Win SY, Horio F, Sato J, Motai Y, Seo H, Fujisawa S, Sato T, Oishi E, Htun LL, Bawm S, Okagawa T, Maekawa N, Konnai S, Ohashi K, Murata S.   +14 more
europepmc   +1 more source

Evolutionary Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reveals Genomic Divergence with Implications for Universal Vaccine Efficacy. [PDF]

Vaccines (Basel), 2020
Yellapu NK, Patel S, Zhang B, Meier R, Neums L, Pei D, Xia Q, Rotich D, Zimmermann RC, Nissen E, Bell-Glenn S, Shae W, Hu J, Chalise P, Chollet-Hinton L, Koestler DC, Thompson JA.   +16 more
europepmc   +1 more source